Pfizer Inc
(PFE)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2001 | 09-2001 | 06-2001 | 03-2001 | 12-2000 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 7,788,000 | 5,832,000 | 3,759,000 | 1,930,000 | 3,718,000 |
| Depreciation Amortization | 972,000 | 772,000 | 522,000 | 254,000 | 968,000 |
| Income taxes - deferred | 1,348,000 | N/A | N/A | N/A | 43,000 |
| Accounts receivable | 81,000 | N/A | N/A | N/A | -502,000 |
| Other Working Capital | -997,000 | 320,000 | 108,000 | -438,000 | 1,803,000 |
| Other Operating Activity | -331,000 | -107,000 | -152,000 | 51,000 | 165,000 |
| Operating Cash Flow | $8,861,000 | $6,817,000 | $4,237,000 | $1,797,000 | $6,195,000 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -1,410,000 | -1,446,000 | -1,822,000 | -811,000 | -1,390,000 |
| PPE Investments | -2,105,000 | -1,519,000 | -979,000 | -430,000 | -2,100,000 |
| Net Acquisitions | 8,000 | 8,000 | N/A | N/A | 193,000 |
| Purchase Of Investment | -3,708,000 | -2,311,000 | -960,000 | -40,000 | -618,000 |
| Sale Of Investment | 80,000 | 95,000 | 53,000 | 67,000 | 346,000 |
| Other Investing Activity | 0 | 3,000 | -38,000 | -28,000 | -184,000 |
| Investing Cash Flow | $-7,135,000 | $-5,170,000 | $-3,746,000 | $-1,242,000 | $-3,753,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 2,344,000 | 2,120,000 | 551,000 | 126,000 | 1,224,000 |
| Debt Issued | 1,837,000 | 1,238,000 | 1,246,000 | 753,000 | 18,000 |
| Debt Repayment | -151,000 | -30,000 | -3,000 | N/A | -529,000 |
| Common Stock Issued | 773,000 | 520,000 | 410,000 | 181,000 | 1,188,000 |
| Common Stock Repurchased | -3,665,000 | -2,213,000 | -868,000 | -484,000 | -1,005,000 |
| Dividend Paid | -2,715,000 | -2,038,000 | -1,359,000 | -680,000 | -2,197,000 |
| Other Financing Activity | -519,000 | -411,000 | -242,000 | -370,000 | -2,404,000 |
| Financing Cash Flow | $-2,096,000 | $-814,000 | $-265,000 | $-474,000 | $-3,705,000 |
| Exchange Rate Effect | -6,000 | -7,000 | -3,000 | -4,000 | 4,000 |
| Beginning Cash Position | 1,099,000 | 1,099,000 | 1,099,000 | 1,099,000 | 2,358,000 |
| End Cash Position | 1,036,000 | 1,898,000 | 1,295,000 | 1,176,000 | 1,099,000 |
| Net Cash Flow | $-63,000 | $799,000 | $196,000 | $77,000 | $-1,259,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 8,861,000 | 6,817,000 | 4,237,000 | 1,797,000 | 6,195,000 |
| Capital Expenditure | -2,105,000 | -1,519,000 | -979,000 | -430,000 | -2,073,000 |
| Free Cash Flow | 6,756,000 | 5,298,000 | 3,258,000 | 1,367,000 | 4,122,000 |